Mitotech

Website: Mitotech
Business Area(s): 


Description: 

Mitotech S.A. is a Luxembourg-based single-molecule biotechnology company with a portfolio of novel drugs, based on mitochondria targeted antioxidants, for the treatment of age-related disorders undergoing early, middle and late stages of drug development. Our drug portfolio consists of an ophthalmic drug (Visomitin™) and a systemic drug (Plastomitin™) that both have our lead compound SkQ1 – a highly efficient mitochondria-targeted antioxidant – as their active ingredient.

Location(s): 
Luxembourg
Luxembourg